The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $37.69

Today's change0.00 0.00%
Updated September 2 4:00 PM EDT. Delayed by at least 15 minutes.
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $37.69

Today's change0.00 0.00%
Updated September 2 4:00 PM EDT. Delayed by at least 15 minutes.

Fresenius Medical Care AG & Co KGaA closed at (U.S.)$37.69.

Shares have lost 1.26% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 9.77% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $37.69
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change+1.48%
  • Volume0
  • Average volume (10-day)171,298
  • Average volume (1-month)212,865
  • Average volume (3-month)183,771
  • 52-week range(U.S.) $32.40 to (U.S.) $44.34
  • Beta0.62
  • Trailing P/E21.71×
  • P/E 1 year forward21.41×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.43
  • Dividend yield1.15%
  • Trailing EPS(U.S.) $1.74
Updated September 2 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.87%

Based on its net profit margin of 7.87%, Fresenius Medical Care AG & Co KGaA is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.47%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue4,1993,9604,3204,113
Total other revenue--------
Total revenue4,1993,9604,3204,113
Gross profit1,2971,1841,4141,288
Total cost of revenue2,9012,7762,9062,825
Total operating expense3,6523,4563,6573,523
Selling / general / administrative714655724670
Research & development34313130
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-----11
Other operating expenses, total--------
Operating income547504663590
Interest income (expense), net non-operating-115-162-162-111
Gain (loss) on sale of assets--------
Other--------
Income before tax445402546491
Income after tax310264403329
Income tax, total135138143162
Net income241210335271
Total adjustments to net income--------
Net income before extra. items241210335271
Minority interest-69-55-67-58
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items241210335271
Inc. avail. to common incl. extra. items241210335271
Diluted net income241210335271
Dilution adjustment0------
Diluted weighted average shares305305304303
Diluted EPS excluding extraordinary itemsvalue per share0.790.691.100.89
Dividends per sharevalue per share0.840.000.530.00
Diluted normalized EPSvalue per share0.790.691.100.90